The role of SIRT1 level and SIRT1 gene polymorphisms in optic neuritis patients with multiple sclerosis

被引:3
|
作者
Kubiliute, Aleksandra [1 ]
Gedvilaite, Greta [2 ]
Vilkeviciute, Alvita [2 ]
Kriauciuniene, Loresa [2 ]
Bruzaite, Akvile [2 ]
Zaliuniene, Dalia [3 ]
Liutkeviciene, Rasa [2 ,3 ]
机构
[1] Lithuanian Univ Hlth Sci, Med Acad, Med Fac, Eiveniu Str 2, LT-50161 Kaunas, Lithuania
[2] Lithuanian Univ Hlth Sci, Neurosci Inst, Med Acad, Lab Ophthalmol, Eiveniu Str 2, LT-50161 Kaunas, Lithuania
[3] Lithuanian Univ Hlth Sci, Med Acad, Dept Ophthalmol, Eiveniu 2 Str, LT-50161 Kaunas, Lithuania
关键词
Optic neuritis; Multiple sclerosis; SIRT1; SNP; ELISA; NEUROPROTECTION; RESVERATROL; ACTIVATION; PROTECTS; DAMAGE; CELLS; MODEL;
D O I
10.1186/s13023-023-02665-x
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The aimTo investigate the role of Sirtuin 1 (SIRT1) level and SIRT1 (rs3818292, rs3758391, rs7895833) gene polymorphisms in patients with optic neuritis (ON) and multiple sclerosis (MS).Methods79 patients with ON and 225 healthy subjects were included in the study. ON patients were divided into 2 subgroups: patients with MS (n = 30) and patients without MS (n = 43). 6 ON patients did not have sufficient data for MS diagnosis and were excluded from the subgroup analysis. DNA was extracted from peripheral blood leukocytes and genotyped by real-time polymerase chain reaction. Results were analysed using the program "IBM SPSS Statistics 27.0".ResultsWe discovered that SIRT1 rs3758391 was associated with a twofold increased odds of developing ON under the codominant (p = 0.007), dominant (p = 0.011), and over-dominant (p = 0.008) models. Also, it was associated with a threefold increased odds ofON with MS development under the dominant (p = 0.010), twofold increased odds under the over-dominant (p = 0.032) models and a 1.2-fold increased odds of ON with MS development (p = 0.015) under the additive model. We also discovered that the SIRT1 rs7895833 was significantly associated with a 2.5-fold increased odds of ON development under the codominant (p = 0.001), dominant (p = 0.006), and over-dominant (p < 0.001) models, and a fourfold increased odds of ON with MS development under the codominant (p < 0.001), dominant (p = 0.001), over-dominant (p < 0.001) models and with a twofold increased odds of ON with MS development (p = 0.013) under the additive genetic model. There was no association between SIRT1 levels and ON with/without MS development.ConclusionsSIRT1 rs3758391 and rs7895833 polymorphisms are associated with ON and ON with MS development.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] Evaluation of Rosuvastatin Therapy on SIRT1 Gene Expression in Patients with Multiple Sclerosis: An Uncontrolled Clinical Trial
    Batoee, Shakiba
    Etminaniesfahani, Maryam
    Mazdeh, Mehrdokht
    Soltanian, Alireza
    Nouri, Fatemeh
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2023, 99
  • [42] SIRT1 GENE PROMOTER REGION POLYMORPHISMS AND SYSTEMIC LUPUS ERYTHEMATOSUS
    Consiglio, Camila R.
    Schauren, Juliana
    Monticielo, Odirlei A.
    Xavier, Ricardo M.
    Brenol, Joao C.
    Chies, Jose A.
    TISSUE ANTIGENS, 2013, 81 (05): : 383 - 383
  • [43] Correlations between SIRT1 gene polymorphisms and diabetic kidney disease
    Yue, Xin-Ge
    Yang, Zai-Gang
    Zhang, Yue
    Qin, Gui-Jun
    Liu, Fei
    ROYAL SOCIETY OPEN SCIENCE, 2018, 5 (06):
  • [44] Association of SIRT1 single gene nucleotide polymorphisms and serum SIRT1 levels with laryngeal squamous cell carcinoma patient survival rate
    Vaiciulis, Paulius
    Liutkeviciene, Rasa
    Liutkevicius, Vykintas
    Vilkeviciute, Alvita
    Gedvilaite, Greta
    Uloza, Virgilijus
    CANCER BIOMARKERS, 2022, 34 (02) : 175 - 188
  • [45] SIRT1 and NAD + precursors: Therapeutic targets in multiple sclerosis a review
    Nimmagadda, Vamshi K. C.
    Makar, Tapas K.
    Chandrasekaran, Krish
    Sagi, Avinash Rao
    Ray, Jayanta
    Russell, James W.
    Bever, Christopher T., Jr.
    JOURNAL OF NEUROIMMUNOLOGY, 2017, 304 : 29 - 34
  • [46] Upregulation of SIRT1 gene in gastric adenocarcinoma
    Ozcan, Onder
    Belli, Ahmet Korkut
    Cetin, Esin Sakalli
    Kara, Murat
    Celik, Ozgur Ilhan
    Kaplan, Mehmet
    Kayilioglu, Selami Ilgaz
    Donmez, Cem
    Polat, Murat
    TURKISH JOURNAL OF GASTROENTEROLOGY, 2019, 30 (04): : 326 - 330
  • [47] DJ-1 activates SIRT1 through its direct binding to SIRT1
    Takahashi-Niki, Kazuko
    Ganaha, Yoko
    Niki, Takeshi
    Nakagawa, Shota
    Kato-Ose, Izumi
    Iguchi-Ariga, Sanae M. M.
    Ariga, Hiroyoshi
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2016, 474 (01) : 131 - 136
  • [48] SIRT1 is regulated by a PPARγ-SIRT1 negative feedback loop associated with senescence
    Han, Limin
    Zhou, Rui
    Niu, Jing
    McNutt, Michael A.
    Wang, Pan
    Tong, Tanjun
    NUCLEIC ACIDS RESEARCH, 2010, 38 (21) : 7458 - 7471
  • [49] SIRT1 protein levels in cancer Tuning SIRT1 to the needs of a cancer cell
    Deppert, Wolfgang
    CELL CYCLE, 2008, 7 (19) : 2947 - 2948
  • [50] Active regulator of SIRT1 is required for cancer cell survival but not for SIRT1 activity
    Knight, John R. P.
    Allison, Simon J.
    Milner, Jo
    OPEN BIOLOGY, 2013, 3 (11)